CCJ AI Stock Analysis – Buy, Hold, or Avoid?
Cameco Corporation (CCJ)
Fundamentals
Cameco Corporation (CCJ) exhibits solid financial stability supported by positive revenue trends and improving profitability in recent years, despite volatility in quarterly earnings. The company's core uranium mining and production business benefits from an improving market environment driven by global nuclear energy demand. While recent EPS missed expectations and share price has corrected from highs, underlying fundamentals remain intact with a cautious outlook given sector cyclicality and geopolitical risks.
Financial Highlights
- Revenue
- Net Income
- Net Margin (%)
Revenue
-7.17% YoY
Q2 2026
Net Income
-92.14% YoY
Q2 2026
Net Margin
Q2 2026
Growth Metrics
Revenue Growth YoY
Latest Quarter: Q2 2026
Net Income Growth YoY
Latest Quarter: Q2 2026
Revenue Per Share Growth YoY
Latest Quarter: Q2 2026
EPS Growth YoY
Latest Quarter: Q2 2026
Book Value Per Share Growth YoY
Latest Quarter: Q2 2026
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 814.1M | 845.4M | 1.2B | 614.6M | 877.0M | 789.4M | 1.2B | 720.6M |
| Revenue Growth YoY | -7.17% | +7.09% | +1.42% | -14.72% | +46.55% | +24.61% | +40.23% | +25.30% |
| Net Income | 25.2M | 131.1M | 198.9M | -141.0K | 320.9M | 69.8M | 135.5M | 7.4M |
| Net Income Growth YoY | -92.14% | +87.90% | +46.82% | -101.90% | +791.11% | +1088.72% | +69.12% | -94.98% |
| EPS | $0.06 | $0.31 | $0.45 | -$0.00 | $0.74 | $0.16 | $0.31 | $0.02 |
| EPS Growth YoY | -92.16% | +93.75% | +45.16% | -101.75% | +825.00% | +900.00% | +72.22% | -94.97% |
Profitability Metrics
Technical Analysis
CCJ is currently in a strong bearish trend with price trading below key moving averages and exhibiting a death cross between the 50-day and 200-day SMAs. Momentum indicators like MACD confirm bearish momentum, while RSI remains neutral but closer to oversold. Key support levels near $80 and $85 are critical, with resistance around $108 and higher levels above $126.
No extreme reading
Price in downtrend
Strong trend active
50 below 200 - bearish
Key Technical Values
Price with Moving Averages
50-day, 150-day and 200-day simple moving averages
Relative Strength Index
Momentum oscillator measuring speed and magnitude of price changes
RSI (14)
Earnings
Cameco Corporation (CCJ) exhibits solid financial stability supported by positive revenue trends and improving profitability in recent years, despite volatility in quarterly earnings. The company's core uranium mining and production business benefits from an improving market environment driven by global nuclear energy demand. While recent EPS missed expectations and share price has corrected from highs, underlying fundamentals remain intact with a cautious outlook given sector cyclicality and geopolitical risks.
Latest Earnings
Q2 2026 Earnings (Jun 30, 2026)
Earnings Per Share (EPS)
Actual
$0.13
Estimated
$0.26
Surprise
$-0.13
Surprise %
-50.00%
Revenue
Actual
$573.06M
Estimated
$579.6M
Surprise
-$6.54M
Surprise %
-1.13%
Historical Earnings
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share | ||||||||
| EPS (Actual) | $0.13 | $0.34 | $0.36 | $0.05 | $0.51 | $0.11 | $0.26 | $-0.01 |
| EPS (Estimated) | $0.26 | $0.29 | $0.29 | $0.14 | $0.27 | $0.09 | $0.16 | $0.14 |
| EPS Surprise | -$0.13 | +$0.05 | +$0.07 | -$0.09 | +$0.24 | +$0.02 | +$0.10 | -$0.15 |
| % Diff | -50.0% | +17.2% | +24.1% | -64.6% | +87.6% | +18.0% | +59.7% | -107.3% |
| Revenue | ||||||||
| Revenue (Actual) | $573.06M | $607.49M | $874.57M | $440.62M | $643.71M | $554.33M | $822.19M | $530.99M |
| Revenue (Estimated) | $579.6M | $598.63M | $806.26M | $389.39M | $427.79M | $396.35M | $533.14M | $410.58M |
| Revenue Surprise | -$6.54M | +$8.85M | +$68.31M | +$51.23M | +$215.92M | +$157.98M | +$289.04M | +$120.41M |
| % Diff | -1.1% | +1.5% | +8.5% | +13.2% | +50.5% | +39.9% | +54.2% | +29.3% |
Valuation
Cameco Corporation (CCJ) currently trades at premium valuation multiples, reflecting significant market optimism driven by strong uranium market fundamentals and growth prospects. While valuation multiples like P/E and EV/EBITDA are elevated compared to historical and sector norms, positive supply-demand dynamics and long-term contracts support the premium. Analyst consensus also points to considerable upside potential with moderately bullish recommendations.
Valuation Metrics
Price to Earnings
TTM
Price to Sales
TTM
Price to Book
TTM
Enterprise Value to EBITDA
TTM
Enterprise Value to Revenue
TTM
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Price to Earnings | 624.18 | 126.07 | 68.30 | -97333.33 | 34.17 | 92.56 | 59.60 | 944.59 |
| Price to Sales | 77.37 | 77.94 | 45.57 | 82.97 | 50.20 | 32.67 | 27.19 | 39.02 |
| Price to Book | 8.83 | 9.33 | 7.93 | 7.52 | 6.53 | 3.97 | 5.06 | 4.53 |
| Enterprise Value to EBITDA | 375.35 | 261.96 | 154.97 | 561.64 | 175.55 | 106.35 | 116.12 | 170.54 |
| Enterprise Value to Revenue | 77.24 | 77.85 | 45.50 | 83.34 | 50.53 | 33.48 | 27.78 | 40.73 |
Sentiment & Analyst Ratings
Cameco Corporation (CCJ) sentiment is moderately positive, supported by strong analyst buy ratings and optimism about its uranium market exposure. Despite a weaker Q2 earnings report, positive news around strategic developments and an elevated uranium price outlook bolster confidence. However, valuation concerns and cautious options sentiment temper overall enthusiasm.
Analyst Recommendations
Risk Assessment
Cameco Corporation exhibits a strong financial foundation with robust liquidity and low leverage, supporting its operational resilience despite recent earnings pressures and production disruptions. The uranium sector's cyclicality and geopolitical sensitivities introduce moderate long-term risks, though the company's strategic assets and contract backlog provide buffering strength. Market sentiment is cautiously optimistic amid raised price and revenue guidance but tempered by operational challenges and valuation concerns.
Liquidity & Solvency
Current Ratio
Latest Quarter: Q2 2026
Quick Ratio
Latest Quarter: Q2 2026
Debt-to-Equity
Latest Quarter: Q2 2026
Debt-to-Assets
Latest Quarter: Q2 2026
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Liquidity Metrics | ||||||||
| Current Ratio | 3.06 | 3.08 | 2.47 | 2.99 | 2.96 | 2.71 | 1.62 | 2.88 |
| Quick Ratio | 2.10 | 2.09 | 1.68 | 1.57 | 1.75 | 0.99 | 0.80 | 0.96 |
| Solvency Metrics | ||||||||
| Debt-to-Equity | 0.14 | 0.14 | 0.15 | 0.15 | 0.15 | 0.15 | 0.20 | 0.23 |
| Debt-to-Assets | 0.10 | 0.10 | 0.10 | 0.10 | 0.11 | 0.11 | 0.13 | 0.15 |
Liquidity Assessment
Current Ratio: 3.06(Strong)
Quick Ratio: 2.10(Strong)
The company has strong liquidity with sufficient short-term assets to cover liabilities.
Solvency Assessment
Debt-to-Equity: 0.14(Low)
Debt-to-Assets: 0.10(Low)
The company has conservative debt levels, indicating low financial risk and strong long-term solvency.
Frequently Asked Questions about CCJ
AI Answers: Common Questions About CCJ
Get AI-powered answers to the questions investors ask most about Cameco Corporation
CCJ is a good long-term buy given its strong market position and growth in uranium demand, but short-term technical weakness suggests caution. The P/E ratio near 68 and recent earnings misses indicate risk for near-term investors.
Short-term traders may consider selling or avoiding new positions due to bearish technical signals and recent EPS misses. Long-term holders should only sell if uranium prices weaken significantly or operational risks materialize.
Key risks include uranium price fluctuations, geopolitical tensions affecting supply, operational disruptions, regulatory changes, and the stock’s high valuation which may correct if growth slows.
Analyst price targets vary widely from around $84 to over $200, reflecting differing views on uranium market strength and company execution. Technical resistance lies near $108 and $126, with support at $80 and $69.
CCJ is currently overvalued with elevated P/E (>68), EV/EBITDA, and price-to-sales multiples compared to sector peers, pricing in strong future growth that may be challenged by market volatility.
Fundamentals are solid with 19% revenue growth from 2023 to 2025, improving gross margins (~33%), and robust EBITDA margins above 30%. The company benefits from extensive reserves and long-term contracts.
The technical outlook is bearish with a death cross, negative MACD, and price below key moving averages. Support levels at $80 and $85 are critical; failure to hold may lead to further declines.
Potential catalysts include sustained uranium price increases, global nuclear energy expansion, and the Westinghouse IPO. Earnings releases and operational updates may also influence sentiment and price.
Want a Personalized Answer?
Get AI-powered insights tailored to your risk tolerance and investment goals.